ClinConnect ClinConnect Logo
Search / Trial NCT01865071

Early Closure of Temporary Loop Ileostomy After Rectal Resection for Cancer

Launched by ODENSE UNIVERSITY HOSPITAL · May 26, 2013

Trial Information

Current as of July 22, 2025

Unknown status

Keywords

Ileostomy Rectal Resection Proctectomy Stoma Closure Rectal Cancer

ClinConnect Summary

The aim of this prospective randomized study is to compare early vs. late closer of the protecting ileostoma in patients requiring rectal resection for rectal cancer.

Early closer is defined as postoperative days 8-12 and delayed as later then 3 months.

Inclusion criteria is aged 18 years or older with rectal carcinoma, requiring rectal resection with a protecting ileostoma.

A CT-water-soluble contrast enema examination per rectum is performed at day 7, to evaluate the anastomosis in all patients. The patients will be randomized after the "intention-to-treat" principle, before the primar...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All patients aged 18 years or older.
  • All patients with rectal carcinoma, requiring elective rectal resection with primary anastomosis and an protecting ileostoma
  • Written informed consent was obtained from all patients
  • Exclusion Criteria:

About Odense University Hospital

Odense University Hospital is a leading academic medical center located in Denmark, dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital is committed to enhancing patient outcomes and fostering collaboration among multidisciplinary teams. With a focus on translating scientific discoveries into practical applications, Odense University Hospital leverages its state-of-the-art facilities and expertise to conduct rigorous trials across various medical fields, ensuring adherence to the highest ethical and regulatory standards. Through these efforts, the hospital aims to contribute significantly to the global body of medical knowledge and improve the quality of care for patients both locally and internationally.

Locations

Odense, Fyn, Denmark

Patients applied

0 patients applied

Trial Officials

Mark Ellebæk, MD

Principal Investigator

Odense Universityhospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials